High performance alpha-amylase for starch liquefaction

Engineered alpha-amylases with enhanced stability and activity at low pH and high temperatures address the inefficiencies of existing enzymes, improving starch liquefaction, saccharification, and cleaning applications.

JP2024544155APending Publication Date: 2024-11-28DANISCO US INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024529447
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-18
Filing Date
2022-11-18
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing alpha-amylases used in starch liquefaction and saccharification processes are not sufficiently powerful and efficient, particularly at low pH and high temperatures, necessitating the development of more potent engineered enzymes.

Method used

Development of engineered alpha-amylases with at least 85% amino acid sequence identity to specific sequences, exhibiting enhanced activity and stability at low pH and high temperatures, without the need for additional stabilizers like calcium and sodium ions.

Benefits of technology

The engineered alpha-amylases demonstrate improved performance in starch liquefaction and saccharification, maintaining 50-90% residual activity at pH 5 and 30-70% activity at pH 4.8 after exposure to high temperatures, and are effective in cleaning starchy stains and fabric desizing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544155000001_ABST
    Figure 2024544155000001_ABST
Patent Text Reader

Abstract

Compositions and methods are disclosed that relate to engineered α-amylases that outperform commercially available combinatorial variant α-amylases that are currently the industry standard. The engineered α-amylases are useful for starch liquefaction and saccharification, and may also be useful in cleaning starchy stains, desizing fabrics, baking, and brewing.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Patent Application No. 63 / 280,891, filed November 18, 2021, which is incorporated by reference in its entirety.

[0002] Disclosed are compositions and methods for engineered α-amylases designed for efficient starch liquefaction. The engineered α-amylases outperform commercially available combinatorial variant α-amylases that are currently the industry standard. The engineered α-amylases are useful for starch liquefaction and saccharification, and may also be useful in cleaning starchy stains, desizing fabrics, baking, and brewing. [Background technology]

[0003] Starch consists of a mixture of amylose (15-30 w / w%) and amylopectin (70-85 w / w%). Amylose consists of linear chains of α-1,4-linked glucose units with a molecular weight (MW) of about 60,000 to about 800,000. Amylopectin is a branched polymer containing α-1,6 branch points every 24-30 glucose units, and its MW can reach 100 million.

[0004] Starch-derived sugars in the form of concentrated dextrose syrup are currently produced by an enzyme-catalyzed process that involves (i) gelatinization and liquefaction (or viscosity reduction) of solid starch with α-amylase to dextrins with an average degree of polymerization of about 7-10, and (ii) saccharification of the resulting liquefied starch (i.e., starch hydrolysate) with glucoamylase. The resulting syrup has a high glucose content. Much of the commercially produced glucose syrup is subsequently enzymatically isomerized to a dextrose / fructose mixture known as isosyrup. The resulting syrup can also be fermented using microorganisms such as yeast to produce commercial products including, for example, ethanol, citric acid, lactic acid, succinic acid, itaconic acid, monosodium glutamate, gluconate, lysine, other organic acids, other amino acids, and other biochemicals. Fermentation and saccharification can be carried out simultaneously (i.e., via a simultaneous saccharification and fermentation (SSF) process) to achieve greater economy and efficiency.

[0005] Alpha-amylases hydrolyze starch, glycogen and related polysaccharides by randomly cleaving internal alpha-1,4-glucosidic bonds. Alpha-amylases, particularly from Bacillus genus, are used for a wide variety of purposes, including starch liquefaction and saccharification, textile desizing, starch modification in the pulp and paper industry, brewing, baking, production of syrups for the food industry, production of feedstock for fermentation processes and animal feed to increase digestibility. These enzymes can also be used to remove starchy soils and stains during dishwashing and laundry washing. Summary of the Invention [Problem to be solved by the invention]

[0006] Numerous publications have described single and multiple (i.e., combinatorial) mutations of α-amylases. However, there is a need for even more potent engineered α-amylase molecules that outperform those produced using conventional strategies. [Means for solving the problem]

[0007] Compositions and methods of the invention relate to engineered α-amylase polypeptides and methods of use thereof. Aspects and embodiments of the compositions and methods of the invention are summarized in the individually numbered paragraphs below. 1. In a first aspect, there is provided a non-naturally occurring engineered α-amylase having at least 85% amino acid sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and / or SEQ ID NO:4 and having α-amylase activity. 2. In some embodiments, a nucleic acid encoding a non-naturally engineered α-amylase as described in paragraph 1 is provided. 3. In some embodiments, an expression vector is provided that comprises the nucleic acid described in paragraph 2. 4. In some embodiments, a cell is provided that comprises an expression vector described in paragraph 3. 5. In some embodiments, a cell is provided that expresses the non-naturally engineered α-amylase described in paragraph 1. 6. In some embodiments, a formulated composition is provided comprising the non-naturally engineered α-amylase described in paragraph 1. 7. In some embodiments, a method is provided for saccharifying a composition comprising starch to produce a composition comprising glucose, the method comprising: (i) contacting a solution comprising starch with an effective amount of any of the variant amylases described in paragraph 1; and (ii) saccharifying the solution comprising starch to produce a composition comprising glucose, wherein the variant amylase catalyzes the saccharification of the starch solution to glucose. These and other aspects and embodiments of the present compositions and methods will be apparent from the description and drawings of the invention. [Brief description of the drawings]

[0008] [Figure 1]Clustal W amino acid sequence alignment of engineered α-amylases 1-4 and native α-amylase from Bacillus licheniformis and Bacillus stearothermophilus. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] 1. Overview Compositions and methods are described for engineered α-amylase enzymes that exhibit enhanced high temperature liquefaction performance at low pH in the absence of additional stabilizers such as calcium and sodium ions. The engineered α-amylases exhibited 50-90% residual activity at pH 5, 30-70% activity at pH 4.8, and 10-35% activity at pH 4.5 after a brief incubation at 110° C. for 7-9 minutes followed by a 2 hour incubation at 95° C.

[0010] Engineered α-amylases are obviously useful for starch liquefaction and saccharification, but may also be useful for cleaning starchy stains in laundry, dishwashing and other applications, for fabric processing (e.g., desizing), for improving digestibility in animal feed, and for baking and brewing. These and other aspects of the present compositions and methods are described in detail below.

[0011] 2. Definitions and Abbreviations Before describing the various aspects and embodiments of the engineered α-amylases of the present invention and methods of their use, the following definitions and abbreviations are provided.

[0012] It should be noted that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an enzyme" includes a plurality of such enzymes, reference to "a dosage" includes reference to one or more dosages and equivalents thereof known to those skilled in the art, and so forth.

[0013] This specification is organized into a number of sections for ease of reading. However, the reader will understand that statements made in one section may be applicable to other sections. As such, the headings used in the different sections of this disclosure should not be construed as limiting.

[0014] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The following terms are provided below.

[0015] 2.1. Abbreviations and Acronyms The following abbreviations / acronyms have the following meanings unless otherwise specified: DE Dextrose equivalent DNA deoxyribonucleic acid ds or DS dry solid EC Enzyme Committee EOF End of fermentation GA glucoamylase GAU / g ds Glucoamylase activity units / g dry solids HFCS High Fructose Corn Syrup MW molecular weight ppm parts per million, e.g., μg protein per gram of dry solids SSF Simultaneous Saccharification and Fermentation SSU / Solids (g) Soluble Starch Units / Dry Solids (g) sp. species Tm melting temperature w / v weight / volume w / w weight / weight v / v volume / volume wt% Weight percent ℃ Celsius temperature H2O Water DI deionized water g or gm grams mg milligram kg Kilogram mL and ml milliliters mm millimeters mM millimolar concentration M Molar concentration U Units sec seconds min(s) minutes hr(s) time ETOH Ethanol eq. equivalent weight Tris-HCl Tris(hydroxymethyl)aminomethane hydrochloride μg / gds Enzyme protein (μg) per gram of corn starch dry solids nd Not detected

[0016] 2.2.Definition The term "amylase" or "amylolytic enzyme" refers specifically to an enzyme capable of catalyzing the degradation of starch. α-amylase is a hydrolase that cleaves α-D-(1→4) O-glycosidic bonds in starch. In general, α-amylase (EC 3.2.1.1; α-D-(1→4)-glucan glucanohydrolase) is defined as an endo-acting enzyme that randomly cleaves α-D-(1→4) O-glycosidic bonds in starch molecules to produce polysaccharides containing three or more (1-4)-α-linked D-glucose units. In contrast, some product-specific amylases, such as exo-acting amylolytic enzymes, e.g., β-amylase (EC 3.2.1.2; α-D-(1→4)-glucan maltohydrolase) and maltogenic α-amylase (EC 3.2.1.133), cleave polysaccharide molecules from the non-reducing end of the substrate. Product-specific amylases such as β-amylase, α-glucosidase (EC 3.2.1.20; α-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; α-D-(1→4)-glucan glucohydrolase) and maltotetraosidase (EC 3.2.1.60) and maltohexaosidase (EC 3.2.1.98) can produce malto-oligosaccharides of defined length or concentrated syrups of defined malto-oligosaccharides.

[0017] The term "starch" refers to any substance composed of a complex polysaccharide carbohydrate of plants, composed of amylose and amylopectin, having the formula (C6H10O5)x, where X can be any number. The term includes materials obtained from plant-based materials, such as grains, cereals, grasses, tubers and roots, more specifically wheat, barley, corn, rye, rice, sorghum, bran, cassava, millet, milo, potato, sweet potato and tapioca. The term "starch" includes granular starch. The term "granular starch" refers to raw, i.e., uncooked starch, e.g., starch that has not been gelatinized.

[0018] The terms "wild-type," "parent," or "reference" with respect to a polypeptide refer to a naturally occurring polypeptide that does not contain an artificial substitution, insertion, or deletion at one or more amino acid positions. Similarly, the terms "wild-type," "parent," or "reference" with respect to a polynucleotide refer to a naturally occurring polynucleotide that does not contain an artificial nucleoside change. However, it should be noted that a polynucleotide encoding a wild-type, parent, or reference polypeptide is not limited to naturally occurring polynucleotides, but encompasses any polynucleotide that encodes a wild-type, parent, or reference polypeptide.

[0019] Reference to a wild-type polypeptide is understood to include the mature form of the polypeptide. A "mature" polypeptide or variant thereof is one in which the signal sequence is absent, e.g., cleaved from the immature form of the polypeptide during or after expression of the polypeptide.

[0020] The term "variant" with respect to a polypeptide refers to a polypeptide that differs from a given wild-type, parent, or reference polypeptide in that it contains one or more naturally occurring or artificial substitutions, insertions, or deletions of amino acids. Similarly, the term "variant" with respect to a polynucleotide refers to a polynucleotide that differs in nucleotide sequence from a given wild-type, parent, or reference polynucleotide. The identity of the wild-type, parent, or reference polypeptide or polynucleotide will be clear from the context.

[0021] The term "engineered" refers to molecules that have been modified using any number of different methods in combination, including holistic approaches to protein modification that are more complex than creating single or combinatorial mutations. Engineered proteins can be essentially unrecognizable from any particular "parent" molecule and therefore difficult to characterize as "mutants."

[0022] In the case of the α-amylases of the present invention, "activity" refers to α-amylase activity, which can be measured as described herein.

[0023] The term "performance benefit" refers to an improvement in a desirable property of a molecule. Exemplary performance benefits include, but are not limited to, increased hydrolysis of starch substrates, increased liquefaction performance of grains, cereals, or other starch substrates, increased cleaning performance, increased heat resistance, increased detergent stability, increased storage stability, increased solubility, altered pH profile, decreased calcium dependency, increased specific activity, modified substrate specificity, modified substrate binding, modified pH-dependent activity, modified pH-dependent stability, increased oxidative stability, and increased expression. In some cases, the performance benefit is realized at a relatively low temperature. In some cases, the performance benefit is realized at a relatively high temperature.

[0024] The terms "protease" and "proteinase" refer to enzyme proteins capable of performing "proteolysis" or "proteolytic cleavage," which refers to the hydrolysis of the peptide bonds that link amino acids together in the peptide or polypeptide chain that forms a protein. This activity of proteases as protein-digesting enzymes is referred to as "proteolytic activity." There are many well-known procedures for measuring proteolytic activity (see, e.g., Kalisz, "Microbial Proteinases," In: Fiechter (ed.), Advances in Biochemical Engineering / Biotechnology, (1988)).

[0025] "Combinatorial variants" are variants that contain two or more mutations, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more substitutions, deletions and / or insertions.

[0026] The term "recombinant" when used with respect to a subject cell, nucleic acid, protein, or vector indicates that the subject has been modified from its native state. Thus, for example, a recombinant cell expresses a gene not found in the native (non-recombinant) form of the cell, or expresses a native gene at a level or under conditions different from those found in nature. A recombinant nucleic acid differs from a native sequence by one or more nucleotides and / or is operably linked to a heterologous sequence, e.g., a heterologous promoter in an expression vector. A recombinant protein may differ from a native sequence by one or more amino acids and / or is fused to a heterologous sequence. A vector containing a nucleic acid encoding an amylase is a recombinant vector.

[0027] The terms "recovered," "isolated," and "separated" refer to a compound, protein (polypeptide), cell, nucleic acid, amino acid, or other given substance or component that is removed from at least one other substance or component with which it is naturally associated as found in nature. Such "isolated" polypeptides include, but are not limited to, culture broths containing secreted polypeptides expressed in a heterologous host cell.

[0028] The term "purified" refers to a material (e.g., an isolated polypeptide or polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.

[0029] The term "enriched" refers to a material (eg, an isolated polypeptide or polynucleotide) that is about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.

[0030] The terms "thermostable" and "thermostable" in reference to an enzyme refer to the ability of the enzyme to retain activity after exposure to high temperature. The thermostability of an enzyme, such as an amylase enzyme, is measured by its half-life (t1 / 2), given in minutes, hours or days, during which half of the enzyme activity is lost under defined conditions. The half-life can be calculated by measuring the remaining α-amylase activity after exposure to high temperature (i.e., challenge with high temperature).

[0031] "pH range" in reference to an enzyme refers to the range of pH values ​​over which the enzyme exhibits catalytic activity.

[0032] The terms "pH stable" and "pH stability" in reference to an enzyme refer to the ability of the enzyme to retain activity over a wide range of pH values ​​for a specified period of time (eg, 15 minutes, 30 minutes, 1 hour).

[0033] The term "amino acid sequence" is synonymous with, and is used interchangeably with, the terms "polypeptide," "protein," and "peptide." When such amino acid sequences exhibit activity, they may be referred to as "enzymes." Conventional one-letter or three-letter codes for amino acid residues are used, and amino acid sequences are displayed in the standard amino to carboxy terminal direction (i.e., N→C).

[0034] The term "nucleic acid" includes DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids can be single-stranded or double-stranded and can contain chemical modifications. The terms "nucleic acid" and "polynucleotide" are used interchangeably. Because the genetic code is degenerate, more than one codon can be used to code for a particular amino acid, and the compositions and methods of the invention encompass nucleotide sequences that code for a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in the 5' to 3' direction.

[0035] "Hybridization" refers to the process by which one strand of nucleic acid forms a duplex, i.e., base pairs, with a complementary strand, as occurs during blot hybridization and PCR techniques. Stringent hybridization conditions are exemplified by hybridization under the following conditions: 65°C and 0.1xSSC (where 1xSSC = 0.15M NaCl, 0.015M Na3 Citrate, pH 7.0). A hybridized duplex nucleic acid is characterized by the melting temperature (Tm) at which one-half of the hybridized nucleic acid disassociates from the complementary strand. Mismatched nucleotides within the duplex decrease the Tm. An α-amylase-encoding nucleic acid may have a Tm that is 1°C to 3°C or more lower than a duplex formed between the nucleotides of SEQ ID NO:2 and its matching complement.

[0036] A "synthetic" molecule is produced not by a living organism, but by in vitro chemical or enzymatic synthesis.

[0037] The terms "transformed," "stably transformed," and "transgenic" as used with reference to a cell mean that the cell contains a non-native (e.g., heterologous) nucleic acid sequence that is integrated into its genome or maintained as an episome that is maintained for multiple generations.

[0038] The term "introduced" in reference to the insertion of a nucleic acid sequence into a cell means "gene transfer," "transformation," or "transduction," as known in the art.

[0039] A "host strain" or "host cell" is an organism into which an expression vector, phage, virus, or other DNA construct containing a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced. Exemplary host strains are microbial cells (e.g., bacteria, filamentous fungi, and yeast) capable of expressing a polypeptide of interest and / or fermenting sugars. The term "host cell" includes protoplasts produced from cells.

[0040] The term "heterologous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.

[0041] The term "endogenous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally within a host cell.

[0042] The term "expression" refers to the process by which a polypeptide is produced based on a nucleic acid sequence, including both transcription and translation.

[0043] "Selective marker" or "selectable marker" refers to a gene that can be expressed in a host to facilitate selection of host cells that carry the gene. Examples of selectable markers include, but are not limited to, antibacterial agents (e.g., hygromycin, bleomycin, or chloramphenicol) and / or genes that confer a metabolic advantage, such as a nutritional advantage, to the host cell.

[0044] "Vector" refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types. Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes, etc.

[0045] "Expression vector" refers to a DNA construct containing a DNA sequence encoding a polypeptide of interest, the coding sequence being operably linked to a suitable control sequence capable of effecting the expression of the DNA in a suitable host. Such control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding a suitable ribosome binding site on the mRNA, an enhancer, and sequences to control the termination of transcription and translation.

[0046] The term "operably linked" means that the given components are in a relationship, including, but not limited to, juxtaposition, that permits them to function in their intended manner. For example, a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under the control of the regulatory sequence.

[0047] A "signal sequence" is a sequence of amino acids attached to the N-terminal portion of a protein that facilitates secretion of the protein outside the cell. The mature form of the extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.

[0048] "Biologically active" refers to a sequence that has a certain biological activity, such as an enzymatic activity.

[0049] The term "specific activity" refers to the number of moles of substrate that can be converted by an enzyme or enzyme preparation per unit time under given conditions. Specific activity is commonly expressed as units (U) / mg of protein.

[0050] As used herein, "water hardness" is a measure of the minerals (eg, calcium and magnesium) present in water.

[0051] "Cultured cellular material containing amylase" or similar terms refers to a cell lysate or supernatant (including culture medium) that contains amylase as a constituent. The cellular material may be from a heterologous host grown in culture for the purpose of producing amylase.

[0052] "Percent sequence identity" means that a particular sequence has at least a certain percentage of amino acid residues that are identical to those in a given reference sequence when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. The default parameters for the CLUSTAL W algorithm are as follows: Gap Start Penalty: 10.0 Gap extension penalty: 0.05 Protein Weight Matrix: BLOSUM Series DNA Weight Matrix: IUB Delay divergence array (%): 40 Gap Separation Distance: 8 DNA transition weight: 0.50 List of hydrophilic residues: GPSNDQEKR Use Negative Matrix: Off Toggle Residue-Specific Penalty: On Toggle Hydrophilic Penalty:On Toggle End Gap Separation Penalty Off.

[0053] Deletions are counted as residues that are non-identical compared to the reference sequence. Deletions occurring at either end are included. For example, a protein having a five amino acid deletion at the C-terminus of the mature engineered α-amylase of SEQ ID NOs: 1-4 would have about 99% percent sequence identity (612 / 617 identical residues x 100, rounded to the nearest integer) to the original polypeptide. Such truncated polypeptides are encompassed by the term "at least 99% amino acid sequence identity" to the mature polypeptide.

[0054] A "fused" polypeptide sequence is one that is connected, i.e., operably linked, by a peptide bond between two subject polypeptide sequences.

[0055] The term "filamentous fungi" refers to all filamentous forms of the subdivision Eumycotina, in particular the Pezizomycotina species.

[0056] The term "degree of polymerization" (DP) refers to the number (n) of anhydroglucopyranose units in a given sugar. Examples of DP1 are the monosaccharides glucose and fructose. Examples of DP2 are the disaccharides maltose and sucrose. The term "DE" or "dextrose equivalent" is defined as the percentage of reducing sugars, i.e., D-glucose, as a fraction of the total carbohydrates in a syrup.

[0057] The term "dry solids content" (ds) refers to the total solids of the slurry on a dry weight percent basis. The term "slurry" refers to an aqueous mixture containing insoluble solids.

[0058] The phrase "simultaneous saccharification and fermentation (SSF)" refers to a process for the production of biochemicals in which a microbial organism, such as an ethanol-producing microorganism, and at least one enzyme, such as an amylase, are present in the same process step. SSF involves the simultaneous hydrolysis of starch substrates (granular, liquefied, or solubilized) to sugars (including glucose) and the fermentation of the sugars to alcohol or other biochemicals or biological materials in the same reaction vessel.

[0059] "Ethanologenic microorganism" refers to a microorganism with the ability to convert sugars or oligosaccharides into ethanol.

[0060] The term "fermented beverage" refers to any beverage produced by a method that includes a fermentation process, such as microbial fermentation, e.g., bacterial and / or fungal fermentation. "Beer" is an example of such a fermented beverage, and the term "beer" is meant to include any fermented wort produced by fermentation / brewing of starch-containing plant material.

[0061] The term "malt" refers to any malted cereal, for example malted barley or malted wheat.

[0062] The term "auxiliary substance" refers to any starch and / or sugar containing vegetable substance that is not malt, such as barley malt or wheat malt. Examples are well known in the art and are widely used in special fermentation products and cheap beer.

[0063] The term "mash" refers to an aqueous slurry of, for example, milling grain, composed of any starch and / or sugar containing vegetable matter, for example, cracked barley malt, cracked barley and / or other auxiliary materials or combinations thereof, mixed with water, which is subsequently separated into wort and spent grain.

[0064] The term "wort" refers to the unfermented liquor that flows out after the milling grains are extracted during mashing.

[0065] The term "about" refers to ±15% of the reference value.

[0066] 3. Engineering α-amylase The compositions and methods of the present invention are based on engineered α-amylase enzymes that outperform conventional α-amylase variants containing either single mutations or combinations of mutations in industrial applications. The engineered molecules were created by combining the knowledge and experience of protein scientists with the use of advanced computational analysis. As such, the engineered α-amylases are difficult to characterize as variants of the parent molecule, but are better characterized as new, non-naturally occurring molecules.

[0067] Herein, we describe and test four engineered α-amylases that share greater than 85% amino acid sequence identity. These molecules represent optimizations of Carbohydrate-Associated Enzyme Database (CAZy) Family 13 amylases, as well as optimizations of any amylase that has previously been referred to by the descriptive term "Termamyl-like." Examples of such α-amylases include those from Bacillus spp., such as B. licheniformis (i.e. BLA and LAT), B. stearothermophilus (i.e. BSG) and B. amyloliquefaciens (i.e. P00692, BACAM and BAA), Bacillus sp. SG-1, Bacillus sp. 707, Bacillus sp. DSM 12368 (i.e. A7-7), Bacillus sp. DSM 12649 (i.e. AA560), Bacillus sp. SP722, B. megaterium (DSM 90 14), Cytophaga sp. (e.g., CspAmy2 amylase) and KSM AP1378.

[0068] The amino acid sequence of the mature form of engineered α-amylase 1 (VES33575M) is shown below as SEQ ID NO:1. [ka]

[0069] The amino acid sequence of the mature form of engineered α-amylase 2 (VES33367M) is shown below as SEQ ID NO:2. [ka]

[0070] The amino acid sequence of the mature form of engineered α-amylase 3 (VES33438M) is shown below as SEQ ID NO:3. [ka]

[0071] The amino acid sequence of the mature form of engineered α-amylase 4 (VES35091M) is shown below as SEQ ID NO:4. [ka]

[0072] As shown in the amino acid sequence alignment in FIG. 1, all four engineered variants have a deletion in the RG1XG2 motif adjacent to the calcium binding loop corresponding to positions R179, G180, I181, and G182 in α-amylase from Bacillus stearothermophilus (SEQ ID NO: 16, shown in bold). This deletion occurs naturally in α-amylase from Bacillus licheniformis (SEQ ID NO: 17). In the engineered α-amylase, this deletion is between residues F176 and K179 (with reference to any of SEQ ID NOs: 1-4). It is noted that it is well known that deletion of either RG1 or XG2 in the motif results in no difference in performance, and the resulting molecules are often difficult to distinguish based on subsequent amino acid sequence analysis.

[0073] In some embodiments, the engineered α-amylase is non-naturally occurring and has at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% or more amino acid sequence homology / identity to any of SEQ ID NOs:1-4.

[0074] In some embodiments, the engineered α-amylases are non-naturally occurring and have any number of conservative amino acid substitutions well recognized in the art. The engineered α-amylases of the invention can be "precursor," "immature," or "full-length," including a signal sequence, or "mature," lacking a signal sequence. The mature form of the polypeptide is generally most useful. The engineered α-amylases of the invention can also be truncated to remove the N- or C-terminus, or extended to include additional N- or C-terminal residues, so long as the resulting polypeptide retains activity.

[0075] Many bacterial (and other) α-amylases are known to share the same fold, often share significant amino acid sequence identity, and sometimes benefit from the same mutations, and therefore mutations described in other Family 13 α-amylases are expected to be transferable to the engineered α-amylases of the present invention.

[0076] 4. Nucleotide Sequences Encoding Engineered α-amylases In another aspect, a nucleic acid encoding an engineered α-amylase is provided. The nucleic acid can encode a particular engineered α-amylase or an α-amylase having a predetermined degree of amino acid sequence identity to a particular engineered α-amylase.

[0077] In one example, the nucleic acid encodes an amylase having at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% homology / identity to any of SEQ ID NOs: 5-8 (excluding the portion of the nucleic acid encoding the signal sequence). It will be understood that due to the degeneracy of the genetic code, multiple nucleic acids may encode the same polypeptide.

[0078] In another example, the nucleic acid hybridizes under stringent or highly stringent conditions to a nucleic acid encoding (or complementary to a nucleic acid encoding) an engineered α-amylase having at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or even at least 99% homology / identity to any of SEQ ID NOs: 1-4. In some embodiments, the nucleic acid hybridizes under stringent or highly stringent conditions to a nucleic acid of any of SEQ ID NOs: 5-8 or complementary to these nucleic acids.

[0079] The nucleic acid can encode a "full-length" ("fl" or "FL") amylase that includes the signal sequence, only the mature form of the amylase that lacks the signal sequence, or a truncated form of the amylase that lacks the N-terminus or C-terminus of the mature form.

[0080] The nucleic acid encoding the α-amylase can be operably linked to a variety of promoters and regulatory elements in a vector suitable for expressing the α-amylase in a host cell. Exemplary promoters are those derived from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA. Such nucleic acids can be linked to other coding sequences, for example, to encode chimeric polypeptides.

[0081] 5. Generation of Engineered α-amylase The engineered α-amylases of the invention can be produced in a host cell, for example by secretion or intracellular expression, using methods well known in the art. A suitable assay can be used to monitor amylase activity in a sample, for example by an assay that directly measures reducing sugars, such as glucose, in the culture medium. For example, glucose concentration can be determined using the Glucose Reagent Kit No. 15-UV (Sigma Chemical Co.) or an instrument such as a Technicon Autoanalyzer. α-amylase activity can also be measured by any known method, such as the PAHBAH or ABTS assays described below.

[0082] Fermentation, separation and concentration techniques are well known in the art and conventional methods may be used to prepare a concentrated variant α-amylase polypeptide-containing solution. After fermentation, a fermentation broth is obtained, from which microbial cells and various suspended solids, including residual fermentation materials, may be removed by conventional separation techniques to obtain an amylase solution. Filtration, centrifugation, microfiltration, rotary vacuum drum filtration, ultrafiltration, ultrafiltration followed by centrifugation, extraction or chromatography, etc., are commonly used.

[0083] 6. Compositions and Uses of Engineered Alpha-Amylases Engineered α-amylases are useful for a variety of industrial applications. For example, engineered α-amylases are useful in starch conversion processes, particularly in saccharification processes of starch undergoing liquefaction. The desired end product can be any product that can be produced by enzymatic conversion of a starch substrate. For example, the desired product can be a syrup rich in glucose and maltose that can be used in other processes, such as the preparation of HFCS, or can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g., gluconate; 2-keto-L-gulonic acid; 5-keto-gluconate; and 2,5-diketogluconate); 1,3-propanediol; aromatic amino acids (e.g., tyrosine, phenylalanine, and tryptophan); organic acids (e.g., lactate, pyruvate, succinate, isocitrate, and oxaloacetate); amino acids (e.g., serine and glycine); antibiotics; antimicrobials; enzymes; vitamins; and hormones.

[0084] The starch conversion process may precede or be simultaneous with a fermentation process designed to produce fuel alcohol or potable alcohol (i.e., drinkable alcohol). Those skilled in the art will recognize the various fermentation conditions that may be used in the production of these end products. Engineered α-amylases are also useful in food preparation compositions and methods. These various uses of engineered α-amylases are described in more detail below.

[0085] 6.1. Preparation of starch substrate Those skilled in the art are well aware of the available methods that can be used to prepare starch substrates for use in the processes disclosed herein.For example, useful starch substrates can be obtained from tubers, roots, stems, legumes, cereals or whole grains.More specifically, granular starch can be obtained from corn, corncob, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, pea, bean, banana or potato.

[0086] Grain-derived starches can be milled or whole, including corn solids such as kernels, bran and / or cobs. The starch can be highly refined raw starch or a feedstock from a starch refining process. A variety of starches are also commercially available.

[0087] The starch substrate can be crude starch from milled whole grains containing non-starch fractions, such as germ residues and fiber. Milling can include either wet milling or dry milling or grinding. In wet milling, the whole grain is soaked in water or dilute acid to separate the grain into its components, such as starch, protein, germ, oil, and grain fiber. Wet milling efficiently separates the germ from the meal (i.e., starch granules and protein), and wet milling is particularly suitable for producing syrups.

[0088] In dry milling or grinding, whole grains are broken down into fine powders and the grains are often processed without being fractionated into their components. In some cases, oil and / or fiber from the grains are recovered. Thus, dry milled grains contain significant amounts of non-starch carbohydrate compounds in addition to starch. Dry milling of starch substrates can be used for the production of ethanol and other biochemicals.

[0089] 6.2. Starch gelatinization and liquefaction Liquefaction refers to the process by which starch is converted to less viscous, shorter chain length dextrins. Generally, the process involves gelatinization of starch, either simultaneously with or followed by the addition of α-amylase, although additional liquefaction-inducing enzymes can be optionally added. The starch substrate is generally slurried with water. The starch slurry may contain starch as a weight percent dry solids of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%. The α-amylases typically used for this application are heat stable. The α-amylase is typically supplied at about 1500 units per kg of dry matter, for example, of starch. To optimize α-amylase stability and activity, the pH of the slurry is typically adjusted to about pH 4.5-6.5, and about 1 mM calcium (about 40 ppm free calcium ions) may also be added depending on the characteristics of the amylase used. Bacterial α-amylase remaining in the slurry after liquefaction can be deactivated by a number of methods, including lowering the pH in a subsequent reaction step or removing calcium from the slurry if the enzyme is calcium-dependent.

[0090] The slurry of starch and engineered α-amylase may be pumped continuously through a jet cooker steam heated to 105°C. Under these conditions, gelatinization occurs rapidly, and enzyme activity combined with high shear forces initiates hydrolysis of the starch substrate. Residence time in the jet cooker is short. The partially gelatinized starch may be passed through a series of holding tubes maintained at 105-110°C and held for 5-8 minutes to complete the gelatinization process ("primary liquefaction"). Hydrolysis to the required DE is completed in a holding tank at elevated temperatures of 85-95°C or higher for about 1-2 hours ("secondary liquefaction"). The slurry is then cooled to room temperature. This cooling step may take 30-180 minutes, e.g., 90-120 minutes. The liquefied starch is typically in the form of a slurry having a dry solids content (w / w) of about 10-50%, about 10-45%, about 15-40%, about 20-40%, about 25-40% or about 25-35%.

[0091] Liquefaction with engineered α-amylases can advantageously be carried out at low pH, eliminating the need to adjust the pH to about pH 4.5-6.5. Engineered α-amylases can be used for liquefaction in a pH range of 2-7, e.g., pH 3.0-7.5, pH 4.0-6.0 or pH 4.5-5.8. The variant amylases can maintain liquefaction activity in a temperature range of about 85°C-95°C, e.g., 85°C, 90°C or 95°C. For example, liquefaction can be carried out with 800 μg of α-amylase in a 25% DS maize starch solution for 10 minutes, e.g., at pH 5.8 and 85°C or pH 4.5 and 95°C.

[0092] 6.3. Saccharification The liquefied starch can be saccharified using glucoamylase, optionally in the presence of another enzyme, to a syrup rich in low DP (e.g., DP1+DP2) sugars. Advantageously, the syrup obtainable using the provided variant amylases can contain a weight percentage of DP2 of more than 30% of the total oligosaccharides in the saccharified starch, such as 45%-65% or 55%-65%. The weight percentage of (DP1+DP2) in the saccharified starch can be more than about 70%, such as 75%-85% or 80%-85%.

[0093] 6.4.Isomerization The soluble starch hydrolysate produced by treatment with amylase can be converted to high fructose starch-based syrup (HFSS), e.g., high fructose corn syrup (HFCS). This can be accomplished using glucose isomerase, particularly glucose isomerase immobilized on a solid support. The pH is raised to about 6.0 to about 8.0 (depending on the isomerase), e.g., pH 7.5, and Ca is added. 2+is removed by ion exchange. Suitable isomerases include SWEETZYME®, IT (Novozymes A / S); G-ZYME® IMGI and G-ZYME® G993, KETOMAX®, G-ZYME® G993, G-ZYME® G993 Liquid and GENSWEET® IGI. After isomerization, the mixture typically contains about 40-45% fructose, for example 42% fructose.

[0094] Fermentation Soluble starch hydrolysates, particularly high glucose syrups, can be fermented by contacting the starch hydrolysates with a fermenting organism, usually an ethanol-producing organism, typically at a temperature of about 32° C., e.g., 30° C. to 35° C. for alcohol-producing yeast. The temperature and pH of the fermentation will depend on the fermenting organism. EOF products include metabolic products such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, lysine and other amino acids, omega-3 fatty acids, butanol, isoprene, 1,3-propanediol, and other biomaterials.

[0095] Ethanol-producing microorganisms include yeasts, such as Saccharomyces cerevisiae, and bacteria, such as Zymomonas mobilis, which express alcohol dehydrogenase and pyruvate decarboxylase. Ethanol-producing microorganisms can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose. For example, improved strains of ethanol-producing microorganisms that can tolerate high temperatures are known in the art and can be used. Microorganisms that produce other metabolic products, such as citric acid and lactic acid, by fermentation are also known in the art.

[0096] The saccharification and fermentation processes may be carried out as SSF processes. Fermentation may include, for example, subsequent concentration, purification and recovery of ethanol. During fermentation, the ethanol content of the broth (or beer) may reach about 8-18 v / v%, for example 14-15 v / v%. The broth may be distilled to produce a concentrated, for example 96% pure ethanol solution. The CO2 produced by fermentation may be collected using a CO2 scrubber, compressed and marketed for other uses, for example, carbonation of beverages or production of dry ice. Solid waste from the fermentation process may be used as a high protein product, for example livestock feed.

[0097] A variation of this process is the "fed-batch fermentation" system, where substrate is added in small increments as the fermentation progresses. Fed-batch systems are useful when catabolite repression may inhibit the metabolism of the cells and when it is desirable to have limited amounts of substrate in the medium. The actual substrate concentration in a fed-batch system is estimated by changes in measurable factors such as pH, dissolved oxygen, and partial pressure of waste gases such as CO2. Batch and fed-batch fermentation are common and well known in the art.

[0098] Continuous fermentation is an open system in which a defined fermentation medium is added continuously to a bioreactor and an equal amount of conditioned medium is simultaneously removed for processing. Continuous fermentation generally maintains the culture at a constant high density, with the cells primarily in logarithmic growth phase. Continuous fermentation allows for the regulation of cell growth and / or product concentration. For example, the limiting nutrient, such as the carbon or nitrogen source, is maintained at a constant ratio, and all other parameters can be adjusted. Since growth is maintained at steady state, cell loss due to medium removal must be balanced against the cell growth rate during fermentation. Methods for optimizing continuous fermentation processes to maximize the rate of product formation are well known in the field of industrial microbiology.

[0099] 6.6. Compositions Comprising Engineered α-Amylases The engineered α-amylase can be combined with a glucoamylase (EC 3.2.1.3), such as a Trichoderma glucoamylase or variant thereof. Alternatively, the glucoamylase can be another glucoamylase derived from a plant (including algae), a fungus, or a bacterium.

[0100] Other suitable enzymes that may be used together with the engineered α-amylase include phytases, proteases, pullulanases, β-amylases, isoamylases, different α-amylases, α-glucosidases, cellulases, xylanases, other hemicellulases, β-glucosidases, transferases, pectinases, lipases, cutinases, esterases, oxidoreductases, or combinations thereof.

[0101] Compositions comprising the amylases of the invention may be aqueous or non-aqueous formulations, granules, powders, gels, slurries, pastes, etc. that may further comprise any one or more of the additional enzymes listed herein, along with buffers, salts, preservatives, water, co-solvents, surfactants, etc. Such compositions may work in combination with endogenous enzymes or other components already present in the slurry, water bath, washing machine, food or beverage product, etc. (e.g., endogenous plant (including algae) enzymes, residual enzymes from prior processing steps, etc.).

[0102] 7. Compositions and methods for baking and food preparation The compositions and methods of the present invention also relate to food compositions, including, but not limited to, foods, animal feeds and / or food / feed additives comprising the amylase, as well as methods of preparing such food compositions or uses thereof comprising mixing the engineered α-amylase with one or more food ingredients.

[0103] Furthermore, the compositions and methods of the invention relate to the use of the engineered α-amylases in the preparation of food compositions, where the food composition is baked following the addition of a polypeptide of the invention.

[0104] Engineered α-amylases may further be added, alone or in combination with other amylases, to prevent or delay staling, i.e., crumb hardening, of baked products. The amount of anti-staling amylase is typically in the range of 0.01-10 mg enzyme protein per kg flour, e.g., 0.5 mg / kg (ds). Additional anti-staling amylases that may be used in combination with one amylase include endoamylases, e.g., bacterial endoamylases from Bacillus.

[0105] The bread-making composition comprising amylase may further comprise a phospholipase or an enzyme with phospholipase activity. An enzyme with phospholipase activity has an activity that can be measured in lipase units (LU). The phospholipase may have A1 or A2 activity for removing fatty acids from phospholipids to form lysophospholipids. The phospholipase may or may not have lipase activity, i.e. activity on triglyceride substrates. The phospholipase typically has an optimum temperature in the range of 30-90°C, for example 30-70°C. The added phospholipase may be of animal origin, for example from pancreas (for example bovine or porcine pancreas), snake venom or bee venom. Alternatively, the phospholipase may be of microbial origin, for example from filamentous fungi, yeast or bacteria.

[0106] Phospholipase is added in an amount to improve bread softness during the initial period after bread making, particularly during the first 24 hours. The amount of phospholipase is typically in the range of 0.01-10 mg enzyme protein per kg flour, e.g., 0.1-5 mg / kg. Thus, phospholipase activity is generally in the range of 20-1,000 LU / kg flour, where a lipase unit is defined as the amount of enzyme required to liberate 1 μmol butyric acid per minute at 30° C. and pH 7.0 using gum arabic as emulsifier and tributyrin as substrate.

[0107] The composition of the dough generally comprises wheat meal or flour and / or other types of meal, flour or starch, such as corn flour, corn starch, rye meal, rye flour, oat flour, oatmeal, soy flour, sorghum meal, sorghum flour, potato meal, potato flour or potato starch. The dough can be fresh, frozen or par-baked. The dough can be leavened or dough undergoing leavening. The dough can be leavened in various ways, for example by adding a chemical leavening agent, such as sodium bicarbonate, or by adding leaven, i.e. leavening dough. The dough can also be leavened by adding a suitable yeast culture, such as a culture of Saccharomyces cerevisiae (baker's yeast), such as a commercially available strain of S. cerevisiae.

[0108] The dough may also contain other conventional dough ingredients, such as proteins, such as milk powder, gluten and soy; eggs (e.g., whole eggs, egg yolks or egg whites); oxidizing agents, such as ascorbic acid, potassium bromate, potassium iodate, azodicarbonamide (ADA) or ammonium persulfate; amino acids, such as L-cysteine; sugar; or salts, such as sodium chloride, calcium acetate, sodium sulfate or calcium sulfate. The dough may further contain fats, such as triglycerides, such as granulated fats or shortening. The dough may further contain emulsifiers, such as mono- or diglycerides, diacetyl tartaric acid esters of mono- or diglycerides, sugar esters of fatty acids, polyglycerol esters of fatty acids, lactic acid esters of monoglycerides, acetic acid esters of monoglycerides, polyoxyethylene stearates or lysolecithin. In particular, the dough may be produced without the addition of emulsifiers.

[0109] The dough product can be any processed dough product, including fried, deep-fried, roasted, baked, steamed and boiled dough, such as steamed bread and mochi. In one embodiment, the food product is a bakery product. Typical bakery (baked) products include bread, such as loaf bread, rolls, buns, bagels, pizza bases, pastries, pretzels, tortillas, cakes, cookies, biscuits, crackers, etc.

[0110] Optionally, additional enzymes can be used together with the anti-staling α-amylase and phospholipase. The additional enzyme may be a second amylase, such as an amyloglucosidase, β-amylase, cyclodextrin glucanotransferase, or the additional enzyme may be a peptidase, in particular an exopeptidase, a transglutaminase, a lipase, a cellulase, a xylanase, a protease, a protein disulfide isomerase, such as the protein disulfide isomerases disclosed in WO 95 / 00636, such as a glucosyltransferase, a branching enzyme (1,4-α-glucan branching enzyme), 4-α-glucanotransferase (dextrin glycosyltransferase) or an oxidoreductase, such as a peroxidase, a laccase, glucose oxidase, amadoriase, a metalloproteinase, a pyranose oxidase, a lipooxygenase, an L-amino acid oxidase or a carbohydrate oxidase. The additional enzymes may be of any origin, including mammalian and plant, and in particular of microbial (bacterial, yeast or fungal) origin, and may be obtained by techniques conventionally used in the art.

[0111] The engineered α-amylase may be used in a premix containing flour together with an anti-staling amylase, a phospholipase and / or a phospholipid. The premix may contain other dough improving additives and / or bread improving additives, such as any of the enzyme-containing additives mentioned above. The amylase may be a component of an enzyme preparation containing an anti-staling amylase and a phospholipase for use as a bread making additive.

[0112] 8. Textile desizing compositions and their uses Also contemplated are compositions and methods for treating textiles (e.g., desizing fabrics) using engineered α-amylases. Textile treatment methods are well known in the art. For example, the feel and appearance of textiles can be improved by methods that include contacting the textile with an amylase in a solution. The textile can be treated with the solution under pressure.

[0113] The engineered α-amylase may be applied during or after weaving of the fabric or during the desizing stage or during one or more additional textile processing steps. The engineered α-amylase may be applied during or after weaving to remove these sizing starches or starch derivatives. After weaving, amylases may be used to remove the sizing coating prior to further processing of the textile to ensure a uniform, wash-resistant result.

[0114] The engineered α-amylases can be used as detergent additives, alone or in conjunction with other desizing chemicals and / or desizing enzymes, to desize textiles, including cotton-containing textiles, for example in aqueous compositions. The engineered α-amylases can also be used in compositions and methods for producing a stonewashed look on indigo dyed denim textiles and garments.

[0115] 9. Cleaning Compositions One aspect of the compositions and methods of the invention is a cleaning composition comprising an engineered α-amylase as a component. The engineered α-amylase polypeptides can be used as components in detergent compositions for, for example, hand washing, laundry washing, dish washing, and other hard surface cleaning. Such compositions include heavy duty liquid (HDL), heavy duty dry (HDD), and hand (manual) laundry detergent compositions, including unit dose laundry detergent compositions, and automatic dishwashing (ADW) and hand (manual) dishwashing compositions, including unit dose dishwashing compositions.

[0116] Preferably, the engineered α-amylase is incorporated into the detergent at or near the concentration conventionally used for α-amylases in detergents. For example, the engineered α-amylase polypeptide may be added in an amount equivalent to 0.00001-1 mg of amylase (calculated as pure enzyme protein) per liter of wash / dishwashing liquor. Exemplary formulations are essentially endless, and the mere description (or claim of novelty) of a known or slightly modified detergent formulation using the engineered α-amylase of the present invention should never be presumed to be an invention with true comparative data.

[0117] 10. Brewing Composition The engineered α-amylase of the present invention can be a component of a brewing composition used in the brewing process, i.e., in producing a fermented malt beverage. Non-fermentable carbohydrates form the majority of the dissolved solids in the final beer. This residue remains due to the inability of malt amylase to hydrolyze the α-1,6-linkages in starch. Non-fermentable carbohydrates contribute approximately 50 calories per 12 ounces of beer. The engineered α-amylase, in combination with glucoamylase and optionally pullulanase and / or isoamylase, converts starch to dextrins and fermentable sugars, helping to reduce the residual non-fermentable carbohydrates in the final beer.

[0118] All references cited herein are incorporated by reference in their entirety for all purposes. To further illustrate the present compositions and methods and their advantages, the following specific examples are provided with the understanding that they are illustrative and not limiting. EXAMPLES

[0119] Example 1 Construction of engineered α-amylase mutant strains Four engineered α-amylases were synthetically assembled. The identity and associated amino acid and nucleic acid sequence information of the engineered α-amylases are summarized in Table 1. The engineered α-amylase numbers and internal reference numbers are used interchangeably. [Table 1]

[0120] To express these α-amylases, DNA cassettes overexpressing engineered α-amylase 1, 2, 3 or 4 were integrated into the cat locus of B. licheniformis strain BF62, respectively (WO 2018156705 A1). The expression cassette contained a downstream homology arm (SEQ ID NO:15) relative to the cat gene, which was operably linked to DNA encoding a kanamycin resistance protein gene expression cassette (SEQ ID NO:9), operably linked to a synthetic p3 promoter (SEQ ID NO:10), operably linked to DNA encoding a B. subtilis aprE 5'UTR (SEQ ID NO:11), operably linked to DNA encoding a modified B. licheniformis amyL signal sequence (SEQ ID NO:12), operably linked to DNA encoding alpha-amylase 1, 2, 3 or 4 (SEQ ID NO:5, 6, 7 or 8), operably linked to a B. licheniformis amyL transcription terminator (SEQ ID NO:13), and operably linked to DNA encoding an upstream homology arm relative to the cat gene (SEQ ID NO:14). DNA cassettes overexpressing engineered α-amylase 1, 2, 3 or 4 were constructed using chemical DNA synthesis and / or overlap extension PCR techniques.

[0121] Each of the four α-amylase overexpression DNA cassettes was used to transform strain BF62 using the method described in WO2018156705A1. Briefly, BF62 competent cells were generated by incubating BF62 cells in Luria Broth containing 100 ppm spectinomycin at 37°C with shaking. The next day, fresh Luria Broth containing 100 ppm spectinomycin was used again to transform BF62 cells at OD 600The culture was diluted until the β-amylase activity was 0.7. The culture was grown for 1 hour at 37°C with shaking at 250 RPM and D-xylose was added to induce comK expression. The culture was grown for an additional 4 hours at 37°C with shaking at 250 RPM. The cells were harvested by centrifugation at 1700g and used as competent cells for transformation with the α-amylase 1, 2, 3 and 4 DNA cassettes. BF62 competent cells were mixed with an aliquot of the DNA cassettes. The cell / DNA mixture was incubated for 1.5 hours at 37°C with shaking at 1200 rpm and subsequently plated on Heart Infusion (HI) agar plates containing 3 mg / L neomycin trisulfate hydrate (Sigma-Aldrich, N1876-25G). The plates were incubated for 48 hours at 37°C. Transformed colonies expressing each of the four engineered α-amylases individually were screened by PCR amplification to confirm the expected integration.

[0122] Colonies expressing each of the α-amylases were grown overnight in Luria broth supplemented with 5 mg / L neomycin trisulfate hydrate and stored at -80°C in 20 v / v% glycerol.

[0123] To obtain sufficient quantities of the engineered α-amylase to assay enzymatic performance, the cells were cultured using standard small-scale or laboratory-scale fermentation conditions (see, e.g., WO 2018 / 156705 and WO 2019 / 055261).

[0124] The relevant amino acid and nucleic acid sequences are shown below: The amino acid sequence of the mature form of engineered α-amylase 1 (VES33575M) is shown as SEQ ID NO:1. [ka]

[0125] The amino acid sequence of the mature form of engineered α-amylase 2 (VES33367M) is shown below as SEQ ID NO:2. [ka]

[0126] The amino acid sequence of the mature form of engineered α-amylase 3 (VES33438M) is shown below as SEQ ID NO:3. [ka]

[0127] The amino acid sequence of the mature form of engineered α-amylase 4 (VES35091M) is shown below as SEQ ID NO:4. [ka]

[0128] The nucleic acid sequence encoding the mature form of engineered α-amylase 1 is shown below as SEQ ID NO:5. [ka]

[0129] The nucleic acid sequence encoding the mature form of engineered α-amylase 2 is shown below as SEQ ID NO:6. [ka]

[0130] The nucleic acid sequence encoding the mature form of engineered α-amylase 3 is shown below as SEQ ID NO:7. [ka]

[0131] The nucleic acid sequence encoding the mature form of engineered α-amylase 4 is shown below as SEQ ID NO:8. [ka]

[0132] Nucleic acid sequence of the kanamycin resistance protein gene expression cassette; underlined is coding sequence (SEQ ID NO:9) [ka]

[0133] The nucleic acid sequence of the synthetic p3 promoter is shown below as SEQ ID NO:10. GTCGCTGATAAACAGCTGACATCAATATCCTATTTTTTCAAAAAATATTTTAAAAAGTTGTTGACTTAAAAGAAGCTAAATGTTATAGTAATAAA

[0134] The nucleic acid sequence of the B. subtilis aprE 5'-UTR region is shown below as SEQ ID NO:11. ACAGAATAGTCTTTTAAGTAAGTCTACTCTGAATTTTTTTAAAAGGAGAGGGTAAAGA

[0135] The nucleic acid sequence encoding the modified B. licheniformis amyL signal peptide coding sequence is shown below as SEQ ID NO:12. ATGAAACAACAAAAACGGCTTTACGCCCGATTGCTGACGCTGTTATTTGCGCTCATCTTCTTGCTGCCTCATTCTGCAGCTTCAGCA

[0136] The nucleic acid sequence of the B. licheniformis amyL transcription terminator is shown below as SEQ ID NO:13. AAGAGCAGAGAGGACGGATTTCCTGAAGGAAATCGTTTTTTTTTT

[0137] The nucleic acid sequence of the upstream homology arm of the native B. licheniformis cat gene is shown below as SEQ ID NO:14. [ka]

[0138] The nucleic acid sequence of the downstream homology arm of the native B. licheniformis cat gene is shown below as SEQ ID NO:15. [ka]

[0139] Example 2 Laboratory-scale liquefaction assay The liquefaction performance of the four engineered α-amylases cloned and expressed in Example 1 was evaluated using a lab-scale corn starch liquefaction assay. Briefly, a corn starch slurry of 35% dry solids was prepared by mixing together 9.75 g corn starch (Ingredion BUFFALO 034010-102) and 15.25 g Milli-Q water in a sample canister. The pH was adjusted to a preselected value using 1 M potassium hydroxide or sulfuric acid solution. The α-amylase was then added and mixed. Incubation was carried out in a rapid viscoanalyzer (Perten RVA 4800) at 90°C, ramped to 110°C over 2 minutes, held at 110°C for 7 minutes, and then cooled to 95°C over 1 minute. The reaction mixture was transferred to a 50 mL conical tube and further incubated at 95°C in a water bath (Thermofisher) for 2 hours. A portion of each reaction mixture was diluted 200-fold with 20 mM sulfuric acid solution and used to measure dextrose equivalent (DE).

[0140] The DE of the liquefaction was determined by measuring the amount of reducing sugars (as glucose equivalents) using a BCA assay kit (Generay). 100 μL of BCA working solution and 5 μL of each 200-fold diluted sample were mixed in a PCR microplate (Axygen), which was incubated at 95° C. for 3 minutes in a thermocycler (T100, Bio-Rad) and then cooled to 20° C. 80 μL of each sample was then transferred to a new microplate (Costar 9017) and the absorbance was read at 562 nm. The amount of reducing sugars in the samples was determined by comparison with known glucose standards. The DE was then calculated as the percentage (w / w) of glucose equivalents relative to the total carbohydrate in the sample. The control enzymes used in all examples are listed in Table 2. [Table 2]

[0141] The liquefaction performance of α-amylases under low pH (i.e., 4.5 and 4.8) is summarized in Tables 3 and 4, respectively. Of all the samples tested, VES33367M showed the best performance at pH 4.5 with equal enzyme dosage. At pH 4.8, VES33367M, VES33438M, VES35091M and VES33575 all gave acceptable DE results. Table 5 lists the liquefaction performance above pH 5.0. VES33367M and VES33438M showed stable performance from pH 5.0 to pH 5.8 under low enzyme dosage with less variation in DE. For some samples, the DE was not determined due to high viscosity (nd). [Table 3] [Table 4] [Table 5]

[0142] Example 3 Laboratory-scale glycation assay The liquefacts of Example 2 with DE values ​​between 10 and 14 were selected for evaluation in the saccharification assay. Prior to saccharification, the liquefacts were adjusted to pH below 3 and heated at 95°C for 30 min before being adjusted back to pH 4.5. For the saccharification assay, 95 μL of each liquefact was transferred to a new microplate (Corning 3357) and 0.16 GAU / gds of glucoamylase (OPTIMAX® 4060, Danisco US Inc.) was added to initiate the saccharification reaction. The plates were incubated at 60°C for 48 h in an iEMS shaking incubator (Thermofisher). At the end of the incubation, the reaction mixture was diluted 40-fold with 5 mM sulfuric acid. The DP composition was analyzed by HPLC using a ROA-Fast acid H+ column at 80°C and a RID detector. A 5 mM sulfuric acid solution was used as the mobile phase at a flow rate of 1 mL / min. The results are summarized in Table 6. [Table 6]

[0143] Example 4 Specific activity assay 1% (w / v) corn starch (Ingredion Inc.) with 5 ppm Ca 2+ and 20 ppm Na + The corn starch was dissolved in 50 mM potassium acetate buffer at pH 4.5 containing 5 ppm Ca. The dissolved corn starch was boiled in a microwave oven and then cooled to room temperature overnight with gentle stirring. Each of the four engineered α-amylase molecules (i.e., VES33367M, VES33575, VES33438M, VES35091M) was diluted with SPEZYME® HT™ and SPEZYME® SL™ in 5 ppm Ca. 2+ and 20 ppm Na +The enzyme was diluted to 0.2 ppm in 20 mM potassium acetate buffer, pH 4.5, containing 0.002% TWEEN 80® (Sigma-Aldrich). 90 μL of 1% substrate was mixed with 9 μL of 0.2 ppm enzyme in a 96-well PCR microtiter plate and incubated at 95° C. for 30 minutes in a thermoblock. After incubation, the reactions were cooled to 25° C.

[0144] Alpha amylase activity was measured by detecting reducing sugar equivalents generated in a starch assay using the Pierce BCA Protein Assay Kit (ThermoFisher, 23224). After the reactions were cooled to room temperature, 10 μL of reaction mixture was added to 90 μL of BCA reagent in a 96-well PCR microtiter plate. This mixture was heated to 95° C. for 3 minutes. 80 μL of the heated BCA reaction was then transferred to a polystyrene reading plate and absorbance was measured at 562 nm.

[0145] Table 7 shows the relative enzymatic activity of selected molecules compared to the SPEZYME® HT™ and SPEZYME® SL™ benchmark amylases, where the activity of the benchmark molecules was set to 100%. Activity at high temperature was significantly higher for all four engineered α-amylases compared to both benchmark α-amylases. [Table 7]

[0146] Example 5 Thermal stability measurements 1% (w / v) corn starch (Ingredion Inc.) with 80 ppm Ca 2+ and 320 ppm Na +The corn starch was dissolved in 50 mM potassium acetate buffer at pH 5.6 containing 5 ppm Ca. The dissolved corn starch was boiled in a microwave oven and then cooled to room temperature overnight with gentle stirring. Each of the four engineered α-amylase molecules (i.e., VES33367M, VES33575, VES33438M, VES35091M) was diluted with SPEZYME® HT™ and SPEZYME® SL™ in 5 ppm Ca. 2+ and 20 ppm Na + and 0.002% TWEEN 80® (Sigma-Aldrich) to 0.04 ppm in 50 mM potassium acetate buffer, pH 4.5. 90 μL of 1% substrate was mixed with 9 μL of 0.04 ppm unstressed enzyme in a 96-well microtiter plate and incubated at 60° C. for 30 minutes in an iEMS shaking incubator (Thermo Scientific). After incubation, the reactions were cooled to 25° C.

[0147] 50 μL of the 0.04 ppm enzyme dilution was incubated in a 96-well PCR microtiter plate and incubated at 94° C. for 10 min in a thermoblock. After incubation, the microtiter plate was cooled to 25° C. 90 μL of 1% substrate was mixed with 9 μL of 0.04 ppm heat-stressed enzyme in a 96-well microtiter plate and incubated at 60° C. for 30 min in an iEMS shaking incubator (Thermo Scientific). After incubation, the reactions were cooled to 25° C.

[0148] The absorbance and percent remaining activity of the unstressed and stressed enzyme reactions are shown in Table 8. VES33367M shows the highest percent remaining activity along with VES33438M. [Table 8]

Claims

1. A non-naturally occurring engineered α-amylase having at least 85% amino acid sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and / or SEQ ID NO:4 and having α-amylase activity.

2. A nucleic acid encoding the non-naturally occurring engineered α-amylase of claim 1.

3. An expression vector comprising the nucleic acid of claim 2.

4. A cell comprising the expression vector of claim 3.

5. A cell expressing the non-naturally occurring engineered α-amylase of claim 1.

6. A formulated composition comprising the non-naturally engineered α-amylase of claim 1.

7. 1. A method for saccharifying a composition comprising starch to produce a composition comprising glucose, comprising: (i) contacting a solution comprising starch with an effective amount of any of the variant amylases of claim 1; (ii) saccharifying the starch-containing solution to produce the glucose-containing composition; wherein the variant amylase catalyzes the saccharification of the starch solution to glucose.